Delivery Order SPE2DB22D3401-SPE2DB23FT4UJ

Award Date 8/24/23
Potential Completion Date 8/25/23
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp. is for the delivery of the pharmaceutical product Trulicity 3 mg/0.5 ml pen in 0.5 ml quantities. The award, valued at $1,741.68, was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen's Corporate Office division. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5ml. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $1,741.68 and a period of performance through June 28, 2024. This is a firm fixed-price delivery order contract, without a set-aside designation. Amerisourcebergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Trulicity 3 mg/0.5 ml pen 0.5 ml. The contract, valued at $5,660.46, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the U.S. Department of Defense (DoD). The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,177.10 for the supply of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen. The contract, valued at $2,031.96, was awarded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Trulicity 3 mg/0.5 ml pen to the U.S. government. The award, valued at $5,805.60, was made by the Defense Logistics Agency (DLA) Troop Support Medical and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $3,238.48, is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml to the Defense Logistics Agency (DLA). The contract is a firm-fixed-price delivery order with a completion date of May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $1,741.68 for the supply of the pharmaceutical product Trulicity 3 mg/0.5 ml pen. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product Trulicity 0.75 mg/0.5 ml pen 0.5ml. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $3,773.64 and a completion date of May 28, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the delivery of Trulicity 3 mg/0.5 ml pen. The contract, valued at $1,741.68, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB23FT4UJ
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including the medication Trulicity 3 mg/0.5 ml pen. The contract, valued at $1,483.56, is a delivery order contract with a firm fixed price. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific contract award does not have a set-aside designation.

Generated 7/19/24, 9:38 AM